Basic Information
ID: ALA4672622
Type: Functional
Description: Antitumor activity against patient-derived pancreatic cancer cells xenografted in BALB/c mouse model of patient-derived xenograft assessed as reduction in p-PKCdelta protein levels at 6 mg/kg, iv dosed once every 2 days for 18 days by Western blot analysis
Format: BAO_0000218
Organism: Homo sapiens
Cell type: BXPC-3
Target: Unchecked(ALA612545)
Document: ALA4665887
Antitumor activity against patient-derived pancreatic cancer cells xenografted in BALB/c mouse model of patient-derived xenograft assessed as reduction in p-PKCdelta protein levels at 6 mg/kg, iv dosed once every 2 days for 18 days by Western blot analysis: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4672622
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 480.52 | 3.99 | 3.99 |